The Latest Breaking News from GSK

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

Equities have jumped this year, with the S&P 500 climbing 19%. But buying opportunities may still exist.

The GSK team was excited to learn about the growth of the Lifesciences sector in Telangana and how global companies are leveraging the ecosystem.

The UK’s former chief scientific adviser, a familiar face during Covid, talks about his new role as chair of the London museum and putting its collection at the heart of our climate response

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

The vaccine will help cut up to 175,000 GP visits

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks